SCHEMBL20151481

SCHEMBL20151481

c1ccc(-c2ccc(-n3c4ccccc4c4cc(-c5ccc6c7ccccc7n(-c7nc8ccccc8c8nc9ccccc9n78)c6c5)ccc43)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.50
HPGD P15428 7/20 0.50
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 5/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 5/20 0.42
POLB P06746 3/20 0.42
HSD17B10 Q99714 3/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 4/20 0.40
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HSP90AA1 P07900 1/20 0.36
GAA P10253 1/20 0.35
HIF1A Q16665 1/20 0.35
TYMS P04818 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151040 1.00 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151489 1.00 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151474 0.97 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151054 0.97 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151483 0.97 KDM4E (0.53) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151044 0.97 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151060 0.97 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151467 0.96 KDM4E (0.47) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151442 0.96 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151032 0.96 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031560-B2 Compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-06-08 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031560-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.